New England Journal of Medicine 2019
N Engl J Med 375(19):18341844 Marx N, Husain M, Lehrke M, Verma S, Sattar N (2022) GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes
It reduces appetite and food cravings by signaling the brain to suppress hunger and increase feelings of fullness, leading to decreased food intake
26 GLP-1R expression occurs in not only the pancreas alpha and beta-cells but also in the GIT, cardiovascular system, kidney, lung and the central and peripheral nervous system
If a dose of a once-weekly GLP-1 medication is missed, patients should follow product-specific guidance
Cranial MR characteristics of Cerebral Palsy cases and correlation of findings with clinical results